Click the tree to learn the origin of our name
An annual calendar of mental health awareness events. Select a month to explore.
Receive occasional updates on psychiatry, emerging advances in care, and new Arzilence services. (Never about personal treatment)
We respect your privacy. Unsubscribe at any time.
ArziFlow V2 is a complete evolution of the ADHD ecosystem — rebuilt with deeper AI, expanded coaching, new executive function tools, and a redesigned experience rooted in neuroscience and schema therapy.
ArziFlow is a neuroscience-informed productivity framework that balances responsibilities with what connects you to your sense of self. Built for ADHD cognition, it replaces urgency-driven planning with intentional structure rooted in executive function research and schema therapy.
June 9, 2026
Masking doesn't have to be built on shame. When it stems from self-knowledge, it can amplify genuine parts of who you are rather than hide them.
Healthy masking starts with understanding your authentic self — choosing which parts to bring forward, rather than performing who you think others want you to be.
Citation
Shane Thrapp. Can Masking Be a Form of Authenticity? ADDitude Magazine. Updated June 9, 2026.
August 27, 2025
Netflix's latest animated film pairs vibrant music and visuals with a deeper truth: shame doesn't only wound—it can fracture the self.
Shame is often hidden beneath conditions like depression and trauma. Addressing it means restoring coherence, not just managing symptoms.
Citation
Sulman Aziz Mirza, M.D. The Burden of Shame and the Healing of Self in "KPop Demon Hunters." Psychiatric News. 2025;60. doi:10.1176/appi.pn.2025.09.9.8
August 27, 2025
Even though one in eight U.S. adults takes an antidepressant, there's little guidance on how to taper safely. This commentary highlights strategies for recognizing and managing withdrawal, with an emphasis on monitoring and individualized planning.
Safe discontinuation requires as much attention as initiation, yet guidance remains scarce.
Citation
Bryan Shapiro, M.D., M.P.H., and Daniel Cohrs, M.D. Antidepressant Withdrawal. Psychiatric News. 2025;60. doi:10.1176/appi.pn.2025.09.9.1
August 13, 2025
A major Swedish study found ADHD medications—especially stimulants like methylphenidate—were linked with lower risks of suicide attempts, substance misuse, traffic accidents, and criminal convictions.
Treatment decisions in ADHD may affect not just attention, but life-saving outcomes.
Citations
Denis Storey. ADHD Meds May Cut Other Mental Health Risks. Psychiatrist.com. August 18, 2025.
Chang Z, et al. ADHD medications and risks of suicide, substance misuse, accidents, and criminality: a nationwide target trial emulation. BMJ. 2025;390:e083658. doi:10.1136/bmj-2024-083658